Literature DB >> 21910074

Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome.

Guo-lin Wu1, Tian-yi Li, Yong-sheng Fan, Guo-you Yu.   

Abstract

OBJECTIVE: To observe the therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin (OPN) and quality of life (QOL) in patients with primary Sjogren's syndrome (pSS) and to study the correlation between OPN level and the disease.
METHODS: Sixty-eight pSS patients were randomly assigned to two groups: the treatment group (35 cases) treated by Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis combined with hydroxychloroquine sulfate tablet (HCQ) and the control group (33 cases) treated by HCQ only. Both were treated for 3 months. Before and after treatment, immunoglobulin G (IgG) level, erythrocyte sedimentation rate (ESR), and OPN level were measured. The QOL in patients was evaluated using the Short Form-36 Health Survey (SF-36) before and after treatment. Thirty healthy females were taken as the normal control.
RESULTS: Before treatment, levels of IgG, ESR, and OPN in patients were higher than those in the normal control. After 3 months of treatment, those in both treatment groups decreased but were lower in the treatment group than those in the control group (P<0.05). The scores of 8 dimensions of SF-36 were lower in the pSS patients than those in the normal control (P<0.05) and higher in the treatment group than in the control group after treatment (P<0.05). Furthermore, there was a positive correlation between the levels of OPN and the levels of IgG and ESR, and a negative correlation between OPN levels and the overall score of SF-36 (P<0.05).
CONCLUSIONS: Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis could alleviate pSS disease and improve the QOL. In addition, the OPN level might be used as an evaluating index for pSS disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910074     DOI: 10.1007/s11655-011-0850-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  8 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease".

Authors:  Thomas Blom; Ahnders Franzén; Dick Heinegård; Rikard Holmdahl
Journal:  Science       Date:  2003-03-21       Impact factor: 47.728

3.  Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection.

Authors:  Carol M Stewart; Kathleen M Berg; Seunghee Cha; Westley H Reeves
Journal:  J Am Dent Assoc       Date:  2008-03       Impact factor: 3.634

4.  Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.

Authors:  L J Dawson; V L Caulfield; J B Stanbury; A E Field; S E Christmas; P M Smith
Journal:  Rheumatology (Oxford)       Date:  2004-12-08       Impact factor: 7.580

5.  [Effects of Chinese herbal medicine for Yiqi Yangyin Quyu in treating Sjögren's syndrome and on patients' immunologic function].

Authors:  Guo-lin Wu; Yong-mei Han; Yong-sheng Fan
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2006-04

6.  A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression.

Authors:  Tina Hummelshoj; Lars P Ryder; Hans O Madsen; Niels Odum; Arne Svejgaard
Journal:  Mol Immunol       Date:  2005-07-11       Impact factor: 4.407

7.  Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation.

Authors:  Renato Ricci; Aurelio Quesada; Carlo Pignalberi; Josè Roda; Marcello Disertori; Alessandro Capucci; Antonio Raviele; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2004-02       Impact factor: 1.900

8.  High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation.

Authors:  Annalisa Chiocchetti; Manuela Indelicato; Thea Bensi; Riccardo Mesturini; Mara Giordano; Selina Sametti; Luca Castelli; Flavia Bottarel; Maria Clorinda Mazzarino; Letizia Garbarini; Francesca Giacopelli; Guido Valesini; Claudio Santoro; Irma Dianzani; Ugo Ramenghi; Umberto Dianzani
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

  8 in total
  6 in total

1.  The osteopontin transgenic mouse is a new model for Sjögren's syndrome.

Authors:  Sehba Husain-Krautter; Jill M Kramer; Wentian Li; Benchang Guo; Thomas L Rothstein
Journal:  Clin Immunol       Date:  2015-01-05       Impact factor: 3.969

2.  Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren's syndrome.

Authors:  Guo-lin Wu; Na-yuan Wu; Tian-yi Li; Yong-sheng Fan; Guo-you Yu; Wen-wen Lu
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

3.  Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial.

Authors:  Lei Wan; Jian Liu; Chuan-bing Huang; Yuan Wang; Xi Chen; Wan-dong Zhang; Gui-zhen Wang; Hai-xia Fan; Yao Ge; Rui-lian Chen; Yun-xiang Cao; Rui-kai Zong; Tian-yang Liu
Journal:  Chin J Integr Med       Date:  2016-01-27       Impact factor: 1.978

4.  Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.

Authors:  Katherine M Hammitt; April N Naegeli; Remon W M van den Broek; Julie A Birt
Journal:  RMD Open       Date:  2017-09-17

5.  The Core Pattern Analysis on Chinese Herbal Medicine for Sjögren's syndrome: A Nationwide Population-Based Study.

Authors:  Ching-Mao Chang; Hsueh-Ting Chu; Yau-Huei Wei; Fang-Pey Chen; Shengwen Wang; Po-Chang Wu; Hung-Rong Yen; Tzeng-Ji Chen; Hen-Hong Chang
Journal:  Sci Rep       Date:  2015-04-29       Impact factor: 4.379

Review 6.  SF-36 total score as a single measure of health-related quality of life: Scoping review.

Authors:  Liliane Lins; Fernando Martins Carvalho
Journal:  SAGE Open Med       Date:  2016-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.